Similar articles

• Treatment of Parkinson's disease with carbidopa, a peripheral decarboxylase inhibitor, and levodopa.

  Fermaglich J. Fermaglich J. Med Ann Dist Columbia. 1974 Dec;43(12):587-91. Med Ann Dist Columbia. 1974. PMID: 4532167 No abstract available.
• [Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study].

  Tissot R, de Ajuriaguerra J. Tissot R, et al. Nouv Presse Med. 1973 Feb 3;2(5):315-6. Nouv Presse Med. 1973. PMID: 4686226 French. No abstract available.
• [Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].

  Stammler A, Vielhaber K. Stammler A, et al. Fortschr Neurol Psychiatr Grenzgeb. 1972 Oct;40(10):564-8. Fortschr Neurol Psychiatr Grenzgeb. 1972. PMID: 4565521 Clinical Trial. German. No abstract available.
• L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients.

  Goodwin FK, Murphy DL, Brodie HK, Bunney WE Jr. Goodwin FK, et al. Biol Psychiatry. 1970 Oct;2(4):341-66. Biol Psychiatry. 1970. PMID: 4920729 Review. No abstract available.
• [Decarboxylase inhibitor given in combination with l-dopa. A new therapeutic principal in parkinsonism].

  Dietrichson P. Dietrichson P. Tidsskr Nor Laegeforen. 1973 Oct 10;93(28):2113-5. Tidsskr Nor Laegeforen. 1973. PMID: 4590070 Review. Norwegian. No abstract available.